Glycemic Targets
"last update: 30 April 2024"
- Implementation considerations
Several barriers may hinder the effective implementation and scale-up of the recommendations in this guideline. These factors may be related to the behaviours of patients (or families), the behavior of healthcare professionals, the organization of care, health service delivery or financial arrangements.
Obstacles to effective implementation include:
▪️ Patient engagement
▪️ Collaboration; person centered, team based collaboration between clinician, dietitian, pharmacist and others involved in care delivery
▪️ Behavior changes: information, guidance and support delivered easily and consistently can help assess sustained behavioral changes.
➡️Research needs
▪️ Clinical trials to evaluate the use of other biomarkers such as Fructosamine or glycated albumin to monitor glycemic status in people with diabetes who have conditions where the interpretation of HbA1c cannot be measured.
➡️Monitoring and evaluating the impact of the guideline
Assessment of effectiveness of diabetes services: Measure HbA1C at the recommended times.
➡️Updating of the guidelines:
These guidelines will be updated whenever there is new evidence.
Adapted from ADA “Standards of Care in Diabetes” 2024
